Predictors of positive treatment response to PTNS in women with overactive bladder

Main Article Content

Suneetha Rachaneni
Doyo Enki
Megan Welstand
Thomasin Heggie
Anupreet Dua

Article Details

Rachaneni, S., Enki, D., Welstand, M., Heggie, T., & Dua, A. (2022). Predictors of positive treatment response to PTNS in women with overactive bladder. Clinical Journal of Obstetrics and Gynecology, 5(1), 001–004. https://doi.org/10.29328/journal.cjog.1001097
Case Reports

Copyright (c) 2022 Rachaneni S, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

de Groat WC, Griffiths D, Yoshimura N: Neural control of the lower urinary tract. Comprehensive Physiology. 2015; 5: 327-396. PubMed: https://pubmed.ncbi.nlm.nih.gov/25589273/

Hubscher CH, Gupta DS, Brink TS. Convergence and cross talk in urogenital neural circuitries. J Neurophysiol. 2013; 110: 1997-2005. PubMed: https://pubmed.ncbi.nlm.nih.gov/23926033/

Klingler HC, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. 2000; 56: 766-771. PubMed: https://pubmed.ncbi.nlm.nih.gov/11068296/

Vandoninck V, van Balken MR, Finazzi Agrò E, Petta F, Micali F, et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003; 22: 227-232. PubMed: https://pubmed.ncbi.nlm.nih.gov/12707873/

Wang M, Jian Z, Ma Y, Jin X, Li H, et al. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020; 31: 2457-2471. PubMed: https://pubmed.ncbi.nlm.nih.gov/32681345/

Del Río-Gonzalez S, Aragon IM, Castillo E, Milla-España F, Galacho A, et al. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation. Urology. 2017; 108: 52-58. PubMed: https://pubmed.ncbi.nlm.nih.gov/28687483/

Rostaminia G, Chang C, Pincus JB, Sand PK, Goldberg RP. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Int Urogynecol J. 2019; 30: 1735-1745. PubMed: https://pubmed.ncbi.nlm.nih.gov/30498931/

van Balken MR, Vergunst H, Bemelmans BL. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol. 2006; 49: 360-365. PubMed: https://pubmed.ncbi.nlm.nih.gov/16359781/

Pincus J, Rostaminia G, Chang C, Gafni-Kane A, Goldberg RP. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy. Neurourol Urodynamics. 2019; 38: 1676-1684. PubMed: https://pubmed.ncbi.nlm.nih.gov/31107570/

Iyer S, Laus K, Rugino A, Botros C, Lozo S, et al. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2019; 30: 1253-1259. PubMed: https://pubmed.ncbi.nlm.nih.gov/30467763/

Kopcsay KS, Marczak TD, Jeppson PC, Cameron AP, Khavari R, et al. Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial. Int Urogynecol J. 2022. PubMed: https://pubmed.ncbi.nlm.nih.gov/34993598/